The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The National Institute on Aging—Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials
Open accessAbstract
Introduction: The National Institute on Aging—Alzheimer's Association Research Framework on Alzheimer's disease (AD) represents an important advance in the biological characterization of the AD spectrum. Methods: The National Institute on Aging—Alzheimer's Association Framework is considered as it applies to clinical trials. Results: Using the combination of amyloid (A), tau (T), and neurodegeneration (N) biomarkers, the Framework provides a means of defining the state of patients with regard to Alzheimer pathologic change. The Framework is relevant to clinical trials of disease‐modifying agents, allowing participants to be characterized biologically at baseline. The ATN Framework can also inform trial outcomes. The preclinical phase of the disease after amyloid deposition is defined by A+T−N−, and the transition to prodromal disease and dementia is characterized by the addition of T and N. Most symptomatic patients in clinical trials are in the class of A+T+N− and A+T+N+. Discussion: The National Institute on Aging—Alzheimer's Association Framework on AD represents progress in providing biomarker profiles of participants in the AD spectrum that can be used to help design clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., Hampel, H., Jagust, W. J., Johnson, K. A., Knopman, D. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002923 · Cited by 1,864
Tau positron emission tomographic imaging in aging and early Alzheimer disease
Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734
Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
Viola, K. L., & Klein, W. L. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1386-3 · Cited by 628
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159743.08996.99 · Cited by 550
Person-specific contribution of neuropathologies to cognitive loss in old age
Boyle, P. A., Yu, L., Wilson, R. S., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2018) · Annals of Neurology · doi:10.1002/ana.25123 · Cited by 508
Donohue, M. C., Sperling, R. A., Petersen, R., Sun, C.-K., Weiner, M. W., Aisen, P. S., & Initiative, F. T. A. D. N. (2017) · JAMA · doi:10.1001/jama.2017.6669 · Cited by 452
Kennedy, M. E., Stamford, A. W., Chen, X., Cox, K., Cumming, J. N., Dockendorf, M. F., Egan, M. F., Ereshefsky, L., Hodgson, R. A., Hyde, L. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9704 · Cited by 441
Research works printed but not linked: 2
- U.S. Food and Drug Administration, 2018, Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry, Federal Register, 7060
- Cummings JL, 2017, Defining disease modification for Alzheimer's disease clinical trials, J Prev Alzheimers Dis., 4, 109
Cited by
Sorted by citations
Items 101–141 of 141
Understanding the pathophysiology of alzheimer's disease
Alharbi, S. S., Alharbi, S. S., Alanazi, A. F., & Alomran, R. W. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns10.15185 · Cited by 2
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Jennette, K. J., & Soble, J. R. (2024) · doi:10.1093/med/9780197690024.003.0009 · Cited by 1
Stellick, C., Greenshaw, A. J., Paulden, M., Yap, S., Marshall, T., Kung, J. Y. C., & Spackman, E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307761 · Cited by 1
Gerontologic Biostatistics and Data Science: Aging Research in the Era of Big Data
Chen, C., Murphy, T. E., Speiser, J. L., Bandeen‐Roche, K., Allore, H. G., Travison, T. G., Griswold, M., & Shardell, M. D. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae269 · Cited by 2
Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
Мазеркина, И. А. (2025) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2025-13-1-7-19 · Cited by 1
Production of [18F]NAV4694 on an FX2N synthesis module for imaging amyloid plaques
Kumar, P., Mangalore, S., Joshi, R. K., Murthy, V., Kumar, A., Sitani, K., Vajjala, A., Gurushanthappa, Y., Muralidharan, D., Kumar, M., et al. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.112216 · Cited by 1
Sha, L., Wu, M., Sun, S., Xie, Y., Liu, Y., Li, Z., Liu, R., Wanhua, G., Yan, S., Xu, B., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261418164 · Cited by 1
Yang, X., Zhang, G., Xie, F., Wang, Y., Zheng, Y., Huang, Q., Wang, W., Xu, W., Guan, Y., Liu, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71182 · Cited by 1
Operationalizing the clinical staging scheme in the 2018 NIA–AA research framework
Amariglio, R. E. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00508-6 · Cited by 1
Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer’s Disease
Seo, Y., Jang, H., & Lee, H. (2022) · Life · doi:10.3390/life12020275 · Cited by 1
Azmi, M. B., Ahmed, A., Ahmed, T. F., Imtiaz, F., Asif, U., Zaman, U., Khan, K. A., & Sherwani, A. K. (2023) · ACS Omega · doi:10.1021/acsomega.3c05769 · Cited by 1
Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05104-z · Cited by 1
Three Neurodegenerative Diseases: A Single Hope
Youssef, S. H., Atalah, H. N., Badawy, M. T., El‐Fawal, H. A. N., & Salama, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_3 · Cited by 1
The future of dementia prevention and treatment strategies
直行, 里. (2020) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.57.374 · Cited by 1
Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6
Qu’apporte l’imagerie hybride TEP-IRM dans l’étude des pathologies neuro-dégénératives ?
Idy-Peretti, I., Habert, M., & Kas, A. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.06.021 · Cited by 2
An overview of Alzheimer's disease and its diagnosis using conventional and novel methods
Zhao, X. (2021) · International Conference on Bioinformatics and Biomedical Science (ICBBS) · doi:10.1145/3498731.3498761
Three Neurodegenerative Diseases: A Single Hope
Youssef, S. H., Atalah, H. N., Badawy, M. T., El‐Fawal, H. A. N., & Salama, M. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_3-1
Personalized modeling of neurodegeneration determines dementia severity from EEG recordingsPreprint
Amato, L. G., Vergani, A. A., Lassi, M., Fabbiani, C., Mazzeo, S., Burali, R., Nacmias, B., Sorbi, S., Mannella, R., Grippo, A., et al. (2023) · medRxiv · doi:10.1101/2023.11.06.23298149
Deep Brain Stimulation for Alzheimer’s Disease: A Review of a Potential Treatment in Neurosurgery
Husodo, K. R., & Fa'izah, C. N. (2024) · Jambura Medical and Health Science Journal · doi:10.37905/jmhsj.v3i1.23340
Choroid Plexus Free-Water Correlates with Glymphatic function in Alzheimer Disease: The RJNB-D StudyPreprint
Li, B., Xu, X., Yang, X., Zhang, J., Wang, Y., Selim, M. H., Zheng, Y., Shen, R., Huang, Q., Wang, W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4680360/v1
Biomarkers of Alzheimer’s Disease
Janakiraman, A. K., Chellammal, H. S. J., Raman, K., Ramkanth, S., Khanna, K., Ramachandran, D., Bhupathyraaj, M., & Cheng, Z. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_13-1
Biomarkers of Alzheimer’s Disease
Janakiraman, A. K., Chellammal, H. S. J., Raman, K., Ramkanth, S., Khanna, K., Ramachandran, D., Bhupathyraaj, M., & Cheng, Z. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_13
Li, B., Xu, X., Yang, X., Zhang, J., Wang, Y., Selim, M. H., Zheng, Y., Shen, R., Sun, L., Huang, Q., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5322986/v1
Production of Fluorine-18[18f]-Nav4694 on an Fx2n Synthesis Module for Imaging Amyloid PlaquesPreprint
Kumar, P., Mangalore, S., Joshi, R. K., Murthy, V., Kumar, A., Sitani, K., Vajjala, A., Gurushanthappa, Y., Muralidharan, D., Kumar, M., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5399262
Hung, C.-C., Chao, Y.-P., Lee, Y., Huang, C.-W., Huang, S.-H., Chang, C.-C., & Cheng, C.-H. (2023) · Figshare · doi:10.6084/m9.figshare.24522541
Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25989206
Ahmad, S., Yang, W., Orellana, A., Frölich, L., de Rojas, I., Cano, A., Boada, M., Hernández, I., Hausner, L., Harms, A. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26755654
Ahmad, S., Yang, W., Orellana, A., Frölich, L., de Rojas, I., Cano, A., Boada, M., Hernández, I., Hausner, L., Harms, A. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26755657
Farouk, Y., Nagy, N., Amir, A. M. E., Madbouly, N. A., & El-Khazragy, N. N. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05789-w
Longitudinal Brain Atrophy Patterns in Dementia and Cognitive Decline: the Framingham Heart StudyPreprint
Rehman, H., Tao, Q., Nolan, J. C., Kurniansyah, N., Ang, T. F. A., Crane, P. K., Mukherjee, S., Saykin, A. J., Trittschuh, E. H., Stein, T. D., et al. (2026) · medRxiv · doi:10.64898/2026.04.28.26351854
Current perspectives on the genetics of neurodegenerative diseases: A narrative review
Chaudhary, S., Iyer, S., Narwal, S., Mitra, M., & Tare, M. (2026) · Aging advances. · doi:10.4103/agingadv.agingadv-d-25-00030
Redefining Alzheimer’s disease diagnostics in the age of blood-based biomarkers
Yadav, P. U., Baidya, A. T. K., & Kumar, R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.006
Han, X., Cao, X., Liu, L., Wang, Z., Gao, D., Lv, H., Yang, H., Wang, Y., Cui, C., Li, S., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1778960
Xiong, D., Liu, M., Xie, J., Liu, Z., & Wang, J. (2026) · iScience · doi:10.1016/j.isci.2026.116394
Wasim, R. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02342-y
Ruíz-Vanoye, J. A., Trejo-Macotela, F. R., Díaz-Parra, O., Sossa, H., Fuentes-Penna, A., & Simancas-Acevedo, E. (2026) · International Journal of Combinatorial Optimization Problems and Informatics. · doi:10.61467/2007.1558.2027.v18i1.1551
Botelho, C. V., Carneiro, A. A. M., Regadas, C. M., Cavalcante, C., Ribeiro, I., Rabelo, S., Araujo, V., Ferreira, G., Iepsen, B. D., & Frota, N. A. F. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261494512
Alinaghipour, A. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261485286
Metadata
- Authors
- Cummings, J.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Cummings, Jeffrey
- ORCID
- Cummings, Jeffrey
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2018-06-21
- Volume
- 15
- Issue
- 1
- Pages
- 172-178
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC6417790
- OpenAlex
- W2809499549
- Cited by
- 140
- References
- 54
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 25 · 2023: 18 · 2022: 12 · 2021: 21 · 2020: 21 · 2019: 18
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Scholarship - UNLV (University of Nevada Reno) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (P20GM109025)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Clinical Trials as Topic, Humans, United States, Biomarkers, National Institute on Aging (U.S.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
